Repros Therapeutics' PIPE Round

Repros Therapeutics raised a round of funding on January 14, 2005. Investors include Vivo Capital.

Repros Therapeutics, formerly Zonagen, focuses on the development of oral small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.…

Articles about Repros Therapeutics' PIPE Round: